Tedros Adhanom Ghebreyesus (Denis Balibouse/Pool Photo via AP Images)
In 'historic' public health step, WHO fully endorses GlaxoSmithKline's malaria shot
GlaxoSmithKline won a big endorsement from the WHO on Wednesday.
The organization has approved the British drugmaker’s malaria vaccine for children, it announced, paving the way for full deployment throughout sub-Saharan Africa after a pilot program in Ghana, Kenya and Malawi rolled out in 2019. It’s largely seen as a huge win in a parasitic disease that kills roughly half a million people each year, including more than a quarter million children under 5, almost all of whom live on the African continent.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
